Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma

Saved in:

Bibliographic Details
Other Authors:	Madle, Michael (Other) , Krämer, Isabelle (Other) , Giesen, Nicola (Other) , Schwarzbich, Mark-Alexander (Other) , Wuchter, Patrick (Other) , Egerer, Gerlinde (Other) , Ho, Anthony Dick (Other) , Witzens-Harig, Mathias (Other)
Format:	Article (Journal) Conference Paper
Language:	English
Published:	2014
In:	Blood Year: 2014, Volume: 124, Issue: 21
ISSN:	1528-0020
Online Access:	Verlag, kostenfrei, Volltext: https://ash.confex.com/ash/2014/webprogram/Paper68919.html/
Author Notes:	Michael Madle, Isabelle Herth, Nicola Lehners, Mark-Alexander Schwarzbich, Patrick Wuchter, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig

Similar Items